Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ondansetron - ADial Pharmaceuticals

Next Previous
Search
Drug Profile

Ondansetron - ADial Pharmaceuticals

Alternative Names: AD-04

Latest Information Update: 10 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Virginia
  • Developer ADial Pharmaceuticals; University of Virginia
  • Class Anti-inflammatories; Antiemetics; Antipsychotics; Carbazoles; Drug withdrawal therapies; Imidazoles; Irritable bowel syndrome therapies; Obesity therapies; Small molecules; Smoking cessation therapies
  • Mechanism of Action Serotonin 3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Alcoholism
  • No development reported Obesity; Opioid-related disorders; Smoking withdrawal

Most Recent Events

  • 25 Feb 2025 ADial Pharmaceuticals plans a phase III programme of ondansetron in 2025
  • 18 Feb 2025 Adis Pharmaceuticals has patent protection for "genetic-based approach to treating and diagnosing alcohol use disorder and other drug dependencies" in the US
  • 11 Feb 2025 Adis Pharmaceuticals has patent protection for "methods of identifying patients with specific genetic markers linked to substance use disorders and treating them with AD04" in the US

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top